Abiraterone acetate and prednisone in metastatic castration-resistant prostate cancer: a real-world retrospective study in China

BACKGROUND: This research work was aimed at evaluating the incidence and risk factors of adverse events (AEs) occurring in patients treated with abiraterone acetate (AA) and prednisone (PDN) outside clinical trials. These associations were assessed regarding the survival outcomes. METHODS: The study...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Min, Yan, Jiaqing, Le, Kaidi, Li, Ying, Xing, Nianzeng, Li, Guohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213513/
https://www.ncbi.nlm.nih.gov/pubmed/37251681
http://dx.doi.org/10.3389/fendo.2023.1158949

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213513/
https://www.ncbi.nlm.nih.gov/pubmed/37251681
http://dx.doi.org/10.3389/fendo.2023.1158949

Ejemplares similares